Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II
By
Basil N. Okeahialam
Okechukwu S. Ogah
May 28, 2026
Clinical Scorecard: Cardiovascular Measurements in Extensive Population Research Volume II
At a Glance
Category Detail
Condition Key Mechanisms Obesity and fat distribution, particularly in ectopic sites, are critical in assessing risk. [Source needed] Target Population Various populations with different phenotypes, including obese adolescents and middle-aged individuals. [Source needed] Care Setting
Key Highlights
Body Roundedness Index (BRI) predicts mortality comparably with BMI. [Source needed] Atherogenic index of plasma (AIP) is an independent predictor of hypertension. [Source needed] Triglyceride Glucose Index (TGI) predicts progression to cardiovascular morbidity. [Source needed] Weight adjusted waist index outperforms traditional indices in assessing cardiovascular risk. [Source needed] Inflammation and insulin resistance are key factors in obesity-related cardiovascular diseases. [Source needed] Guideline-Based Recommendations
Diagnosis
Utilize various anthropometric measures beyond BMI for accurate risk assessment. [Source needed] Management
Early intervention is recommended for obese adolescents showing signs of subclinical ASCVD. [Source needed] Monitoring & Follow-up
Consider carotid-intima-media thickness (CIMT) as a vascular marker for ASCVD risk. [Source needed] Risks
Obesity-related inflammation is a significant contributor to ASCVD. [Source needed] Patient & Prescribing Data
Alternative obesity indices may provide better risk stratification and intervention guidance. [Source needed]
Clinical Best Practices
Incorporate non-traditional anthropometric indices in clinical assessments. [Source needed] Use blood biomarkers to enhance universality in obesity metrics. [Source needed] Related Resources & Content
